Showing results (11-20 of 27) with videos related to
Sort By:
Pageof 3
Journal of Neuropathology and Experimental Neurology|May 23, 2018
ESWR1-CREM Fusion in an Intracranial Myxoid Angiomatoid Fibrous Histiocytoma-Like Tumor: A Case Report and Literature ReviewAlbane Gareton, Gaëlle Pierron, Karima Mokhtari, et al.Radiation Oncology (London, England)|June 1, 2013
Salivary gland-sparing other than parotid-sparing in definitive head-and-neck intensity-modulated radiotherapy does not seem to jeopardize local controlEnrique Chajon, Caroline Lafond, Guillaume Louvel, et al.Radiation Oncology (London, England)|January 10, 2015
Impact of head and neck cancer adaptive radiotherapy to spare the parotid glands and decrease the risk of xerostomiaJoel Castelli, Antoine Simon, Guillaume Louvel, et al.Journal of Neuro-Oncology|May 16, 2015
Systematic review and meta-analysis of phase I/II targeted therapy combined with radiotherapy in patients with glioblastoma multiforme: quality of report, toxicity, and survivalMarcos A dos Santos, Jean-Pierre Pignon, Pierre Blanchard, et al.Journal of Neuro-Oncology|July 3, 2017
Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practiceAlexandre Roux, Sophie Peeters, Marc Zanello, et al.British Journal of Neurosurgery|March 1, 2015
Combining intraoperative carmustine wafers and Stupp regimen in multimodal first-line treatment of primary glioblastomasVladislav Pavlov, Philippe Page, Georges Abi-Lahoud, et al.British Journal of Neurosurgery|August 24, 2016
Epileptic seizures in anaplastic gangliogliomasMarc Zanello, Mélanie Pagès, Alexandre Roux, et al.Journal of Neuropathology and Experimental Neurology|August 20, 2016
Clinical, Imaging, Histopathological and Molecular Characterization of Anaplastic GangliogliomaMarc Zanello, Mélanie Pages, Arnault Tauziède-Espariat, et al.Molecular Cancer|March 23, 2024
An international phase II trial and immune profiling of SBRT and atezolizumab in advanced pretreated colorectal cancerAntonin Levy, Daphné Morel, Matthieu Texier, et al.Pageof 3